Quinpirole attenuates the striatal immediate early gene expression, but not the hyperactivity, induced by the serotonin agonist RU-24969

Brain Research

Volumn 852, Issue 2, 2000, Pages 247-254

  Cook, David F ^a   Wirtshafter, David ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

5 HT(1B) receptor; c Fos; D2 receptor; Dopamine; FosB; Fra 2; Locomotor activity; Serotonin; Striatum

Indexed keywords

5 METHOXY 3 (1,2,3,6 TETRAHYDRO 4 PYRIDYL) 1H INDOLE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; QUINPIROLE; SEROTONIN; SEROTONIN 1B AGONIST; SEROTONIN 1B RECEPTOR; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; GENE EXPRESSION; HYPERACTIVITY; IMMEDIATE EARLY GENE; IMMUNOCYTOCHEMISTRY; LOCOMOTION; MALE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RAT;

AKATHISIA, DRUG-INDUCED; ANIMALS; CORPUS STRIATUM; DNA-BINDING PROTEINS; DOPAMINE; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FOS-RELATED ANTIGEN-2; GENE EXPRESSION; GENES, IMMEDIATE-EARLY; INDOLES; LOCOMOTION; MALE; PROTO-ONCOGENE PROTEINS C-FOS; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN AGONISTS; TRANSCRIPTION FACTORS;

EID: 0033986084     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01993-9     Document Type: Article

References (74)

1. Baretta S., Parthasarathy H.B., Graybiel A.M. Local release of GABAergic inhibition in the motor cortex induces immediate-early gene expression in indirect pathway neurons of the striatum. J. Neurosci. 17:1997;4752-4763.
2. S. Baretta, H.A. Robertson, A.M. Graybiel, Neurochemically specialized projection neurons of the striatum respond differently to psychomotor stimulants, in: G.W. Arbuthnott, P.C. Emson (Eds.), Progress in Brain Research, Elsevier, New York, 1993, pp. 201-205.
3. Benloucif S., Galloway M.P. Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis. Eur. J. Pharmacol. 200:1991;1-8.
4. Benloucif S., Keegan J., Galloway M.P. Serotonin-facilitated dopamine release in vivo: pharmacological characterization. J. Pharmacol. Exp. Ther. 265:1993;373-377.
5. Bruninvels A.T., Landwehrmeyer B., Gustafson E.L., Durkin M.M., Mengod G., Branchek T.A., Hoyer D., Palacios J.M. Localization of 5-HT1B, 5-HT1Dalpha, 5-HT1E and 5-HT1F receptor messenger RNA in rodent and primate brain. Neuropharmacology. 33:1994;367-386.
6. Carli M.A., Invernizzi R., Cervo L., Samanin R. Neurochemical and behavioral studies with RU-24969 in the rat. Psychopharmacology. 94:1988;359-364.
7. Cenci M.A., Campbell K., Wictorin K., Bjorklund A. Striatal c-fos induction by cocaine or apomorphine occurs preferentially in output neurons projecting to the substantia nigra in the rat. Eur. J. Neurosci. 4:1992;376-380.
8. Cheetham S.C., Heal D.J. Evidence that RU-24969-induced locomotor activity in C57/B1/6 mice is specifically mediated by the 5-HT1B receptor. Br. J. Pharmacol. 110:1993;1621-1629.
9. Cole A.J., Bhat R.V., Patt C., Worly P.F., Baraban J.M. D1 dopamine receptor activation of multiple transcription factor genes in rat striatum. J. Neurochem. 58:1992;1420-1426.
10. Cook D.F., Wirtshafter D. Serotonin agonist-induced c-fos expression in the rat striatum. Soc. Neurosci. Abst. 21:1995;1424.
11. Cook D.F., Wirtshafter D. Quinpirole attenuates striatal c-fos induction by 5-HT, opioid and muscarinic receptor agonists. Eur. J. Pharmacol. 349:1998;41-47.
12. Costall B., Olley J.E. Cholinergic and neuroleptic induced catalepsy: modification by lesions in the globus pallidus and substantia nigra. Neuropsychopharmacology. 10:1971;581-594.
13. Dragunow M., Lawlor P., Chiasson B., Robertson H. c-fos antisense generates apomorphine and amphetamine-induced rotation. Neuroreport. 5:1993;305-306.
14. Gardner C.R., Guy A.P. Behavioral effects of RU 24969, a 5-HT1 receptor agonist, in the mouse. Br. J. Pharmacol. 78:1983;96P.
15. Gerfen C.R. The neostriatal mosaic: multiple levels of compartmental organization. J. Neur. Transm., Suppl. 36:1992;43-59.
16. Gerfen C.R., Keefe K.A., Gauda E.B. D1 and D2 dopamine receptor function in the striatum: coactivation of D1- and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1-containing neurons. J. Neurosci. 15:1995;8167-8176.
17. Ghosh A., Ginty D.D., Bading H., Greenberg M.E. Calcium regulation of gene expression in neuronal cells. J. Neurobiol. 25:1993;294-303.
18. Goodwin G.M., Green A.R. A behavioral and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors. Br. J. Pharmacol. 84:1985;743-753.
19. Green A.R., Guy A.P., Gardner C.R. The behavioral effects of RU 24969, a suggested 5-HT1 receptor agonist in rodents and the effect on the behavior of treatment with antidepressants. Neuropharmacology. 23:1984;655-661.
20. A.R. Green, D.J. Heal, The effects of drugs on serotonin-mediated behavioral models, in: R.A. Green (Ed.), Neuropharmacology of Serotonin, Oxford, New York, 1985.
21. Harrison M.B., Wiley R.G., Wooten G.F. Selective localization of striatal D1 receptors to striatal neurons. Brain Res. 528:1990;317-322.
22. Heilig M., Engel J.A., Soderpalm B. c-Fos antisense in the nucleus accumbens blocks the locomotor stimulant action of cocaine. Eur. J. Pharmacol. 236:1993;339-340.
23. Hersch S.M., Cilax B.J., Gutekunst C.A., Rees H.D., Heilman C.J., Yung K.K.L., Bolam J.P., Ince E., Yi H., Levey A.I. Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with corticostriatal afferents. J. Neurosci. 15:1995;5222-5237.
24. Hiroi N., Graybiel A.M. Atypical and typical neuroleptic treatments induce distinct programs of transcription factor expression in the striatum. J. Comp. Neurol. 374:1996;70-83.
25. Hooper K.C., Banks D.A., Stordahl L.J., White I.M., Rebec G.V. Quinpirole inhibits striatal and excites pallidal neurons in freely moving rats. Neurosci. Lett. 237:1997;69-72.
26. Hooper M.L., Chiasson B.J., Robertson H.A. Infusion into the brain of an antisense oligonucleotide to the immediate-early gene c-fos suppresses production of fos and produces a behavioral effect. Neuroscience. 63:1994;917-924.
27. 125I] iodocyanopindolol Eur. J. Pharmacol. 118:1985;1-12.
28. Kalkman H.O. RU 24969-induced locomotion in rats is mediated by 5-HT1A receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 352:1995;583-584.
29. LaHoste G.J., Yu J., Marshall J.F. Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity. Proc. Natl. Acad. Sci. U.S.A. 90:1993;7451-7455.
30. LeMoine C., Bloch B. D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNA's in distinct neuronal populations of the dorsal and ventral striatum. J. Comp. Neurol. 355:1995;418-426.
31. Linthorst A.C., De Lang H., De Jong W., Versteeg D.H. Effect of the dopamine D2 receptor agonist quinpirole on the in vivo release of dopamine in the caudate nucleus of hypertensive rats. Eur. J. Pharmacol. 201:1991;125-133.
32. Lucas J.J., Segu L., Hen R. 5-Hydroxytryptamine1B receptors modulate the effect of cocaine on c-fos expression: converging evidence using 5-hydroxytryptamine1B knockout mice and the 5-hydroxytryptamine1B/1D antagonist GR127935. Mol. Pharmacol. 51:1997;755-763.
33. MacGibbon G.A., Lawlor P.A., Bravo R., Dragunow M. Clozapine and haloperidol produce a differential pattern of immediate early gene expression in rat caudate-putamen, nucleus accumbens, lateral septum and island of Calleja. Mol. Brain Res. 23:1994;21-32.
34. MacGibbon G.A., Lawlor P.A., Huges P., Young D., Dragunow M. Differential expression of inducible transcription factors in basal ganglia neurons. Mol. Brain Res. 34:1995;294-302.
35. Martinez D.L., Geyer M.A. A 5-HT1B antagonist blocks effects of RU 24969 on locomotor, but not investigatory, activity in rats. Soc. Neurosci. Abst. 23:1997;519.
36. Maura G., Giardi A., Raiteri M. Release-regulating D2 dopamine receptors are located on striatal glutaminergic nerve terminals. J. Pharmacol. Exp. Ther. 247:1998;680-684.
37. Middlemiss D.N., Hutson P.H. The 5-HT1B receptors. Ann. N. Y. Acad. Sci. 600:1990;132-147.
38. Moratalla R., Vickers E.A., Robertson H.A., Cochran B.H., Graybiel A.M. Coordinate expression of c-fos and junB is induced in the rat striatum by cocaine. J. Neurosci. 13:1993;423-433.
39. Nissbrandt H., Waters N., Hjorth S. The influence of serotonergic drugs on dopaminergic neurotransmission in rat substantia nigra, striatum and limbic forebrain in vivo. Naunyn-Schmiedeberg's Arch. Pharmacol. 346:1992;12-19.
40. Nye H.E., Nestler E.J. Induction of chronic Fos-related antigens in rat brain by chronic morphine administration. Mol. Pharmacol. 49:1996;636-645.
41. Oberlander C. Effects of a potent 5-HT agonist, RU 24969, on the mesocorticolimbic and nigrostriatal dopamine systems. Br. J. Pharmacol. 80:1983;675P.
42. Oberlander C., Blaquiere B., Pujol J.F. Distinct functions for dopamine and serotonin in locomotor behavior: evidence using the 5-HT1 agonist RU 24969 in globus pallidus-lesioned rats. Neurosci. Lett. 67:1986;113-118.
43. C. Oberlander, J.R. Boissier, Haloperidol blocks hyperlocomotion but not the circling behavior induced by the serotonin agonist RU 24969, Proc. 8th Int. Congr. Pharmacol. Abst., Tokyo, 1981, p. 839.
44. Onali P., Olianas M.C., Gessa G.L. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum. Mol. Pharmacol. 28:1985;138-145.
45. O'Neill M.F., Fernandez A.G., Palacios J.M. GR 127935 blocks the locomotor and antidepressant-like effects of RU 24969 and the action of antidepressants in the mouse tail suspension tests. Pharmacol. Biochem. Behav. 53:1996;535-539.
46. O'Neill M.F., Parameswaran T. RU-24969-induced behavioral syndrome requires activation of both 5-TH1A and 5-HT1B receptors. Psychopharmacology. 132:1997;255-260.
47. Palacios J.M., Waeber C., Hoyer D., Mengod G. Distribution of serotonin receptors. Ann. N. Y. Acad. Sci. 600:1990;36-52.
48. Paul M.L., Graybiel A.M., David J.C., Robertson H.A. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. J. Neurosci. 12:1992;3729-3742.
49. Pazos A., Palacios J.M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain: I. serotonin-1 receptors. Brain Res. 346:1985;205-230.
50. Persico A.M., Schindler C.W., O'Hara B.F.O., Brannock M.T., Uhl G. Brain transcription factor expression: effects of acute and chronic amphetamine and injection stress. Mol. Brain Res. 20:1993;91-100.
51. Peters R.V., Aronin N., Schwartz W.J. c-Fos expression in the rat intergeniculate leaflet: photic regulation, co-localization with Fos-B and cellular identification. Brain Res. 728:1996;231-234.
52. Porcella A., Gessa G.L., Pani L. Delta9-tetrahydrocannabinol increases sequence-specific AP-1 DNA-binding activity and Fos-related antigens in the rat brain. Eur. J. Neurosci. 10:1998;1743-1751.
53. Rempel N.L., Callaway C.W., Geyer M.A. Serotonin1B receptor activation mimics behavioral effects of presynaptic serotonin release. Neuropsychopharmacology. 8:1993;201-211.
54. Robertson G.S., Tham C.S., Wilson C., Jakubovic A., Fibiger H.C. In vivo comparisons of the effects of quinpirole and the putative presynaptic dopaminergic agonists B-HT 920 and SND 919 on striatal dopamine and acetylcholine release. J. Pharmacol. Exp. Ther. 264:1993;1344-1351.
55. Robertson G.S., Vincent S.R., Fibiger H.C. Striatonigral projection neurons contain D1 dopamine receptor activated c-fos. Brain Res. 523:1990;288-290.
56. Robertson L.M., Kerppola T.K., Vendrell M., Luk D., Smeyne R.J., Bocchaiaro C., Morgan J.I., Curran T. Regulation of c-fos expression in transgenic mice requires multiple interdependent transcription control elements. Neuron. 14:1995;241-252.
57. Robinson S.W., Caron M.G. Selective inhibition of adenylyl cyclase type V by the dopamine D3 receptor. Mol. Pharmacol. 52:1997;508-514.
58. Rutberg S.E., Saez E., Lo S., Jang S.I., Markova N., Spiegelman B.M., Yuspa S.H. Opposing activities of c-Fos and Fra-2 on AP-1 regulated transcriptional activity in mouse keratinocytes induced to differentiate by calcium and phorbol esters. Oncogene. 15:1997;1337-1346.
59. Santiago M., Westerink B.H. The regulation of dopamine release from nigrostriatal neurons in conscious rats: the role of somatodendritic autoreceptors. Eur. J. Pharmacol. 204(1):1991;79-85.
60. Schwarcz R., Creese I., Coyle J.T., Snyder S.H. Dopamine receptors localized on cerebral cortical afferents to rat corpus striatum. Nature. 271:1978;766-768.
61. See R.E., Sorg B.A., Chapman M.A., Kalivas P.W. In vivo assessment of release and metabolism of dopamine in the ventrolateral striatum of awake rats following administration of dopamine D1 and D2 receptor agonists and antagonists. Neuropharmacology. 30:1991;1269-1274.
62. Sommer W., Bjelke B., Ganten D., Fuxe K. Antisense oligonucleotide to c-fos induces ipsilateral rotational behavior to d-amphetamine. Neuroreport. 5:1993;277-280.
63. Sommer W., Fuxe K. On the role of c-fos expression in striatal transmission: the antisense oligonucleotide approach. Neurochem. Int. 31:1997;425-436.
64. Struthers W.M., Wirtshafter D. Quinpirole attenuates the striatal Fos expression induced by escape behavior. Brain Res. 785:1998;347-350.
65. Suzuki T., Okuno H., Yoshida T., Endo T., Nishina H., Iba H. Difference in transcriptional regulatory function between c-Fos and Fra-2. Nucleic Acids Res. 19:1991;5537-5542.
66. Tricklebank M.D., Middlemiss D.N., Neill J. Pharmacological analysis of the behavioral and thermoregulatory effects of the putative 5-HT1 receptor agonist, RU 24969, in the rat. Neuropharmacology. 25:1986;877-886.
67. Umekage T., Namima M., Fukushima K., Sugita S., Watanabe T. c-fos antisense blocks methamphetamine-induced ambulatory activity reversibly. Neuroreport. 8:1997;407-410.
68. Vaccarino F.M., Hayward M.D., Le H.N., Hartigan D.J., Duman R.S., Nestler E.J. Induction of immediate early genes by cyclic AMP in primary cultures of neurons from rat cerebral cortex. Brain Res., Mol. Brain Res. 19:1993;76-82.
69. Vallar L., Meldolesi J. Mechanisms of signal transduction at the dopamine D2 receptor. Trends Neurosci. 10:1989;74-77.
70. Watson R.E., Wiegand S.J., Clough R.W., Hoffman G.E. Use of cryoprotectant to maintain long-term peptide immunoreactivity and tissue morphology. Peptides. 7:1986;155-159.
71. Wirtshafter D., Asin K.E. Interactive effects of stimulation of D1 and D2 dopamine receptors on Fos-like immunoreactivity in the normosensitive rat striatum. Brain Res. Bull. 35:1994;85-91.
72. Wirtshafter D., Cook D.F. Serotonin-1B agonists induce compartmentally organized striatal Fos expression in rats. Neuroreport. 9:1998;1217-1221.
73. Wirtshafter D., Schardt G., Asin K.E. Compartmentally specific effects of quinpirole on the striatal Fos expression induced by stimulation of D1-dopamine receptors in intact rats. Brain Res. 771:1997;271-277.
74. Yamamoto B.K., Davy S. Dopaminergic modulation of glutamate release in striatum as measured by microdialysis. J. Neurochem. 58:1992;1742-1746.